Matrix metalloproteinases in liver injury, repair and fibrosis

被引:359
作者
Duarte, Sergio [1 ]
Saber, John [1 ]
Fujii, Takehiro [1 ]
Coito, Ana J. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat,Dept Surg, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
Liver; Liver injury; Acute liver injury; Liver ischemia and reperfusion injury; Chronic liver injury; Extracellular matrix; Matrix metalloproteinases; HEPATIC STELLATE CELLS; NITRIC-OXIDE SYNTHASE; REPERFUSION INJURY; TISSUE INHIBITOR; ISCHEMIA/REPERFUSION INJURY; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MOUSE; LETHAL HEPATITIS; COLD ISCHEMIA; TENASCIN-C;
D O I
10.1016/j.matbio.2015.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The liver is a large highly vascularized organ with a central function in metabolic homeostasis, detoxification, and immunity. Due to its roles, the liver is frequently exposed to various insults which can cause cell death and hepatic dysfunction. Alternatively, the liver has a remarkable ability to self-repair and regenerate after injury. Liver injury and regeneration have both been linked to complex extracellular matrix (ECM) related pathways. While normal degradation of ECM components is an important feature of tissue repair and remodeling, irregular ECM turnover contributes to a variety of liver diseases. Matrix metalloproteinases (MMPs) are the main enzymes implicated in ECM degradation. MMPs not only remodel the ECM, but also regulate immune responses. In this review, we highlight some of the MMP-attributed roles in acute and chronic liver injury and emphasize the need for further experimentation to better understand their functions during hepatic physiological conditions and disease progression. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 87 条
[1]   Fibronectin-α4β1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury [J].
Amersi, F ;
Shen, XD ;
Moore, C ;
Melinek, J ;
Busuttil, RW ;
Kupiec-Weglinski, JW ;
Coito, AJ .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1229-1239
[2]  
Arii S, 1996, HEPATOLOGY, V24, P316
[3]   Acute liver failure [J].
Bernal, William ;
Auzinger, Georg ;
Dhawan, Anil ;
Wendon, Julia .
LANCET, 2010, 376 (9736) :190-201
[4]  
Bodey B, 2000, ANTICANCER RES, V20, P4585
[5]   Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway [J].
Boulday, G ;
Fitau, J ;
Coupel, S ;
Soulillou, JP ;
Charreau, B .
SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 :28-36
[6]   Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis [J].
Calabro, Sarah R. ;
Maczurek, Annette E. ;
Morgan, Alison J. ;
Tu, Thomas ;
Wen, Victoria W. ;
Yee, Christine ;
Mridha, Auvro ;
Lee, Maggie ;
d'Avigdor, William ;
Locarnini, Stephen A. ;
McCaughan, Geoffrey W. ;
Warner, Fiona J. ;
McLennan, Susan V. ;
Shackel, Nicholas A. .
PLOS ONE, 2014, 9 (07)
[7]   Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury [J].
Coito, Ana J. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2011, 16 (01) :34-40
[8]   Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer [J].
Cox, Thomas R. ;
Erler, Janine T. .
DISEASE MODELS & MECHANISMS, 2011, 4 (02) :165-178
[9]   Rat liver injury following normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor [J].
Cursio, R ;
Mari, B ;
Louis, K ;
Rostagno, P ;
Saint-Paul, MC ;
Giudicelli, J ;
Bottero, V ;
Anglard, P ;
Yiotakis, A ;
Dive, V ;
Gugenheim, J ;
Auberger, P .
FASEB JOURNAL, 2001, 15 (13) :93-+
[10]   Underlying potential: cellular and molecular determinants of adult liver repair Introduction [J].
Diehl, Anna Mae ;
Chute, John .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05) :1858-1860